Surgery Partners Secures Improved Merger Terms With HealthSpan Following Rival Bid; Stock Up

Surgery Partners (SGRY) and HealthSpan amended their merger agreement, raising the cash offer to $25.00 per share, with potential ticking fees up to $26.61. The deal values SGRY at up to $6.0B. The board prefers HealthSpan's offer over a rival bid of $28.00 per share due to lower risk and faster closing. SGRY stock rose 11.12% in pre-market trading.

Original reporting
Published Nov 9, 2026, 2:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 7:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$SGRY
Bullish
high confidence
Mentioned
$SGRY
Relevance
8/10
AlphAI data visualization · based on rttnews.com
Decision brief

The 30-second read

$SGRYBullishHigh
01

Why it matters

The amended terms increase the cash component and add ticking fees, making the offer more attractive and likely to secure shareholder approval.

02

Market read

The deal's new terms create a clear arbitrage opportunity and may set a precedent for similar healthcare consolidations.

03

What to watch

Bain Capital's rollover may signal confidence but also ties a large shareholder to the transaction, affecting post‑close dynamics.

Relevance 8/10Novelty 9/10Timing: pre‑market today

Background

Surgery Partners (SGRY) is a U.S. provider of outpatient surgical facilities. HealthSpan Partners, linked to Bon Secours Mercy Health, is acquiring SGRY.

Company-level read

Ticker impact

$SGRYBullishHigh confidence
Context

Surgery Partners announced amended merger terms with HealthSpan, raising cash consideration to $25 per share plus potential fees, confirming a $6B deal.

Expected impact

upward pressure as investors price in the higher premium and faster closing timeline

Evidence & confidence

Merger arbitrage traders will buy the target at current levels expecting the deal to close at $25‑$26.61 per share.

Market effects

Consolidation in the outpatient surgery sector may pressure peers' valuations.

U.S. healthcare M&A activity receives a boost, supporting related REITs and service providers.

Limited to U.S. healthcare investors; no broader macro impact.

Counterpoint

If regulatory hurdles or the competing $28 offer re‑emerge, the deal could stall, capping upside.

Key entities

  • Surgery Partners, Inc.

    Target of the merger.

  • HealthSpan Partners

    Acquirer offering the revised cash consideration.

  • Bain Capital

    Major shareholder rolling over its stake into the combined entity.

Related articles

$SGRYMed

Surgery Partners: Q3 Earnings Snapshot

Surgery Partners Inc. (SGRY) reported a Q3 loss of $21.1 million, or 16 cents per share, with adjusted earnings of 16 cents per share. The company's revenue was $815.3 million. The Tennessee-based surgical facilities operator provided these financial results on Monday.

$SGRYHighAI 8/10

SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS

Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS BRENTWOOD, Tenn., November 9, 2026 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced re